FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2339647598> ?p ?o ?g. }

• W2339647598 abstract "We previously demonstrated that the HLA class II transactivator CIITA inhibits HIV-1 replication in T cells by competing with the viral transactivator Tat for the binding to Cyclin T1 subunit of the P-TEFb complex. Here, we analyzed the anti-viral function of CIITA in myeloid cells, another relevant HIV-1 target cell type. We sinvestigated clones of the U937 promonocytic cell line, either permissive (Plus) or non-permissive (Minus) to HIV-1 replication. This different phenotype has been associated with the expression of TRIM22 in U937 Minus but not in Plus cells. U937 Plus cells stably expressing CIITA were generated and HLA-II positive clones were selected by cell sorting and cloning. HLA and CIITA proteins were analyzed by cytofluorometry and western blotting, respectively. HLA-II DR and CIITA mRNAs were quantified by qRT-PCR. Tat-dependent transactivation was assessed by performing the HIV-1 LTR luciferase gene reporter assay. Cells were infected with HIV-1 and viral replication was evaluated by measuring the RT activity in culture supernatants. CIITA was expressed only in HLA-II-positive U937 Minus cells, and this was strictly correlated with inhibition of Tat-dependent HIV-1 LTR transactivation in Minus but not in Plus cells. Overexpression of CIITA in Plus cells restored the suppression of Tat transactivation, confirming the inhibitory role of CIITA. Importantly, HIV-1 replication was significantly reduced in Plus-CIITA cells with respect to Plus parental cells. This effect was independent of TRIM22 as CIITA did not induce TRIM22 expression in Plus-CIITA cells. U937 Plus and Minus cells represent an interesting model to study the role of CIITA in HIV-1 restriction in the monocytic/macrophage cell lineage. The differential expression of CIITA in CIITA-negative Plus and CIITA-positive Minus cells correlated with their capacity to support or not HIV-1 replication, respectively. In Minus cells CIITA targeted the viral transactivator Tat to inhibit HIV-1 replication. The generation of Plus-CIITA cells was instrumental to demonstrate the specific contribution of CIITA in terms of inhibition of Tat activity and HIV-1 restriction, independently from other cellular factors, including TRIM22. Thus, CIITA acts as a general restriction factor against HIV-1 not only in T cells but also in myeloid cells." @default.
• W2339647598 created "2016-06-24" @default.
• W2339647598 creator A5002836937 @default.
• W2339647598 creator A5008054206 @default.
• W2339647598 creator A5009585913 @default.
• W2339647598 creator A5018618408 @default.
• W2339647598 creator A5020886709 @default.
• W2339647598 creator A5079918535 @default.
• W2339647598 creator A5084091903 @default.
• W2339647598 date "2016-04-18" @default.
• W2339647598 modified "2023-10-16" @default.
• W2339647598 title "The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells" @default.
• W2339647598 cites W1552951076 @default.
• W2339647598 cites W1584527031 @default.
• W2339647598 cites W1830857550 @default.
• W2339647598 cites W1965952845 @default.
• W2339647598 cites W1966389947 @default.
• W2339647598 cites W1977121504 @default.
• W2339647598 cites W1977282539 @default.
• W2339647598 cites W1978118673 @default.
• W2339647598 cites W1986868088 @default.
• W2339647598 cites W1994490736 @default.
• W2339647598 cites W2002039213 @default.
• W2339647598 cites W2009154833 @default.
• W2339647598 cites W2010458160 @default.
• W2339647598 cites W2013522291 @default.
• W2339647598 cites W2015848550 @default.
• W2339647598 cites W2018002636 @default.
• W2339647598 cites W2021865624 @default.
• W2339647598 cites W2023921578 @default.
• W2339647598 cites W2030701079 @default.
• W2339647598 cites W2034685935 @default.
• W2339647598 cites W2050892914 @default.
• W2339647598 cites W2055662683 @default.
• W2339647598 cites W2060320549 @default.
• W2339647598 cites W2080821453 @default.
• W2339647598 cites W2086636233 @default.
• W2339647598 cites W2097433834 @default.
• W2339647598 cites W2108180656 @default.
• W2339647598 cites W2112963706 @default.
• W2339647598 cites W2117211286 @default.
• W2339647598 cites W2124253765 @default.
• W2339647598 cites W2124268946 @default.
• W2339647598 cites W2125228907 @default.
• W2339647598 cites W2126028566 @default.
• W2339647598 cites W2127467277 @default.
• W2339647598 cites W2129664184 @default.
• W2339647598 cites W2131608104 @default.
• W2339647598 cites W2134058861 @default.
• W2339647598 cites W2152327707 @default.
• W2339647598 cites W2152892875 @default.
• W2339647598 cites W2154715621 @default.
• W2339647598 cites W2155806129 @default.
• W2339647598 cites W2158779628 @default.
• W2339647598 cites W2166711458 @default.
• W2339647598 cites W2272141132 @default.
• W2339647598 cites W2296449512 @default.
• W2339647598 cites W2339684523 @default.
• W2339647598 cites W319913515 @default.
• W2339647598 doi "https://doi.org/10.1186/s12967-016-0853-5" @default.
• W2339647598 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4835826" @default.
• W2339647598 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27089879" @default.
• W2339647598 hasPublicationYear "2016" @default.
• W2339647598 type Work @default.
• W2339647598 sameAs 2339647598 @default.
• W2339647598 citedByCount "18" @default.
• W2339647598 countsByYear W23396475982017 @default.
• W2339647598 countsByYear W23396475982018 @default.
• W2339647598 countsByYear W23396475982019 @default.
• W2339647598 countsByYear W23396475982021 @default.
• W2339647598 countsByYear W23396475982022 @default.
• W2339647598 countsByYear W23396475982023 @default.
• W2339647598 crossrefType "journal-article" @default.
• W2339647598 hasAuthorship W2339647598A5002836937 @default.
• W2339647598 hasAuthorship W2339647598A5008054206 @default.
• W2339647598 hasAuthorship W2339647598A5009585913 @default.
• W2339647598 hasAuthorship W2339647598A5018618408 @default.
• W2339647598 hasAuthorship W2339647598A5020886709 @default.
• W2339647598 hasAuthorship W2339647598A5079918535 @default.
• W2339647598 hasAuthorship W2339647598A5084091903 @default.
• W2339647598 hasBestOaLocation W23396475981 @default.
• W2339647598 hasConcept C104317684 @default.
• W2339647598 hasConcept C108634530 @default.
• W2339647598 hasConcept C1292079 @default.
• W2339647598 hasConcept C140704245 @default.
• W2339647598 hasConcept C150194340 @default.
• W2339647598 hasConcept C153911025 @default.
• W2339647598 hasConcept C159047783 @default.
• W2339647598 hasConcept C203014093 @default.
• W2339647598 hasConcept C2775890610 @default.
• W2339647598 hasConcept C2776090121 @default.
• W2339647598 hasConcept C2778814158 @default.
• W2339647598 hasConcept C502942594 @default.
• W2339647598 hasConcept C54355233 @default.
• W2339647598 hasConcept C81885089 @default.
• W2339647598 hasConcept C86803240 @default.
• W2339647598 hasConcept C8891405 @default.
• W2339647598 hasConcept C95444343 @default.
• W2339647598 hasConceptScore W2339647598C104317684 @default.
• W2339647598 hasConceptScore W2339647598C108634530 @default.

• next